For Compassionate Use (Pre-Approval Access), including current BMS and heritage Mirati Investigational Medicines, please login and select the Compassionate Use (PAA) Tile.

Welcome to the new Bristol Myers Squibb Investigator Portal!

BMS has moved from a rolling submission process to a request for proposal (RFP) submission process for investigator sponsored research (ISR) in the areas of oncology, hematology, cardiovascular, and immunology & fibrosis. The new RFP based system will ultimately benefit investigators and patients by addressing medical unmet needs in a more focused and efficient manner.


The RFP submission periods will be posted here along with the Areas of Interest (AOIs) for each of the RFP cycles. Please check back at that time or reach out to your Field Medical or BMS Medical contact if you have questions.
  • For independent research with products that are in the early stages of development, please contact your BMS medical representative.
  • There will be no changes for:
    • Ono Pharmaceuticals Co., Ltd. collaborations with Japan, Korea, & Taiwan, Nectar Therapeutics, Ltd. collaborations (NK-214) and non-clinical research studies
    • Global Expert Centers Initiative (GECI) oncology collaborations
    • Requests for support of investigator sponsored research using Apixaban

Select your country to proceed